- Home
- ATLX vs IBIO Comparison
ATLX vs IBIO Comparison
Compare ATLX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATLX | IBIO |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 83.5M |
| IPO Year | 2012 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ATLX | IBIO |
|---|---|---|
| Price | $3.30 | $1.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $4.75 |
| AVG Volume (30 Days) | 160.1K | ★ 664.5K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.08 | ★ 73.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,491.00 | N/A |
| Revenue This Year | $64,564.67 | N/A |
| Revenue Next Year | $785.59 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.55 | $0.77 |
| 52 Week High | $8.25 | $3.82 |
Technical Indicators
Market Signals| Indicator | ATLX | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 42.71 |
| Support Level | $2.99 | $1.30 |
| Resistance Level | $3.92 | $1.52 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 78.13 | 22.50 |
Price Performance
Historical ComparisonAbout ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.